Symbol="FULC"
AssetType="Common Stock"
Name="Fulcrum Therapeutics Inc"
Description="Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States. The company is headquartered in Cambridge, Massachusetts."
CIK="1680581"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="26 LANDSDOWNE STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="237772000"
EBITDA="-111632000"
PERatio="None"
PEGRatio="None"
BookValue="3.819"
DividendPerShare="0"
DividendYield="0"
EPS="-2.24"
RevenuePerShareTTM="0.141"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.263"
ReturnOnEquityTTM="-0.448"
RevenueTTM="4045000"
GrossProfitTTM="-70440000"
DilutedEPSTTM="-2.24"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.886"
AnalystTargetPrice="8.07"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="26.62"
PriceToBookRatio="1.279"
EVToRevenue="7.04"
EVToEBITDA="-0.717"
Beta="2.128"
num_52WeekHigh="15"
num_52WeekLow="2.25"
num_50DayMovingAverage="3.383"
num_200DayMovingAverage="5.78"
SharesOutstanding="61759000"
DividendDate="None"
ExDividendDate="None"
symbol="FULC"
open="3.86"
high="4.16"
low="3.84"
price="3.95"
volume="613298.00"
latest_trading_day="2023-08-04"
previous_close="3.85"
change="0.10"
change_percent="2.5974%"
aroon_positive_momentum_days="38"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="38"
Volume_recent_avg="861620"
Change_recent_avg="-0.02"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.54"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="38"
Aroon_momentum_negative="62"
image_negative_thumbnail_id_1="1106"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_negative_thumbnail_id_2="141"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="670"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
